BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 18596221)

  • 21. Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation.
    Patinkin D; Milman G; Breuer A; Fride E; Mechoulam R
    Eur J Pharmacol; 2008 Oct; 595(1-3):1-6. PubMed ID: 18778813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.
    Hutch CR; Hillard CJ; Jia C; Hegg CC
    Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
    Loría F; Petrosino S; Mestre L; Spagnolo A; Correa F; Hernangómez M; Guaza C; Di Marzo V; Docagne F
    Eur J Neurosci; 2008 Aug; 28(4):633-41. PubMed ID: 18657182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing.
    Wright K; Rooney N; Feeney M; Tate J; Robertson D; Welham M; Ward S
    Gastroenterology; 2005 Aug; 129(2):437-53. PubMed ID: 16083701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid signaling and liver therapeutics.
    Mallat A; Teixeira-Clerc F; Lotersztajn S
    J Hepatol; 2013 Oct; 59(4):891-6. PubMed ID: 23567085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Protease-Activated Receptor-2 in SZ95 Sebocytes and its Role in Sebaceous Lipogenesis, Inflammation, and Innate Immunity.
    Lee SE; Kim JM; Jeong SK; Choi EH; Zouboulis CC; Lee SH
    J Invest Dermatol; 2015 Sep; 135(9):2219-2227. PubMed ID: 25880702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes.
    Im M; Kim SY; Sohn KC; Choi DK; Lee Y; Seo YJ; Kim CD; Hwang YL; Zouboulis CC; Lee JH
    J Invest Dermatol; 2012 Dec; 132(12):2700-8. PubMed ID: 22763784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes.
    Mastrofrancesco A; Ottaviani M; Cardinali G; Flori E; Briganti S; Ludovici M; Zouboulis CC; Lora V; Camera E; Picardo M
    Biochem Pharmacol; 2017 Aug; 138():96-106. PubMed ID: 28461124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut feelings about the endocannabinoid system.
    Di Marzo V; Piscitelli F
    Neurogastroenterol Motil; 2011 May; 23(5):391-8. PubMed ID: 21481098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of endocannabinoid 1 and 2 (CB1; CB2) receptor agonists on luteal weight, circulating progesterone, luteal mRNA for luteinizing hormone (LH) receptors, and luteal unoccupied and occupied receptors for LH in vivo in ewes.
    Tsutahara NM; Weems YS; Arreguin-Arevalo JA; Nett TM; LaPorte ME; Uchida J; Pang J; McBride T; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):17-24. PubMed ID: 21109016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoids and the skeleton: from marijuana to reversal of bone loss.
    Bab I; Zimmer A; Melamed E
    Ann Med; 2009; 41(8):560-7. PubMed ID: 19634029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cannabinoid system and immune modulation.
    Klein TW; Newton C; Larsen K; Lu L; Perkins I; Nong L; Friedman H
    J Leukoc Biol; 2003 Oct; 74(4):486-96. PubMed ID: 12960289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocannabinoid metabolism by cytochrome P450 monooxygenases.
    Zelasko S; Arnold WR; Das A
    Prostaglandins Other Lipid Mediat; 2015; 116-117():112-23. PubMed ID: 25461979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
    Svízenská I; Dubový P; Sulcová A
    Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocannabinoids and Their Pharmacological Actions.
    Pertwee RG
    Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of stearoyl-coenzyme A desaturase and fatty acid delta-6 desaturase-2 expression by linoleic acid and arachidonic acid in human sebocytes leads to enhancement of proinflammatory activity but does not affect lipogenesis.
    Zouboulis CC; Angres S; Seltmann H
    Br J Dermatol; 2011 Aug; 165(2):269-76. PubMed ID: 21457203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Lipid Accumulation under Hypoxia in SZ95 Human Sebocytes.
    Choi K; Jin M; Zouboulis CC; Lee Y
    Dermatology; 2021; 237(1):131-141. PubMed ID: 32088721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of endocannabinoids in cardiovascular shock.
    Malinowska B; Lupinski S; Godlewski G; Baranowska U; Schlicker E
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 8():91-107. PubMed ID: 19258666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
    Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
    PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB
    Navarro G; Borroto-Escuela D; Angelats E; Etayo Í; Reyes-Resina I; Pulido-Salgado M; Rodríguez-Pérez AI; Canela EI; Saura J; Lanciego JL; Labandeira-García JL; Saura CA; Fuxe K; Franco R
    Brain Behav Immun; 2018 Jan; 67():139-151. PubMed ID: 28843453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.